(Q79560877)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17223980%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

title

Mycobacterium bovis bacillus Calmette-Guérin (BCG) induces human CC- and CXC-chemokines in vitro and in vivo (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17223980%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17223980%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

M A O'Donnell

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17223980%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

author name string

X Chen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17223980%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

publication date

1 February 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17223980%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Immunology

24 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17223980%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

volume

147

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17223980%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

page(s)

370-378

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17223980%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17223980%20AND%20SRC:MED&resulttype=core&format=json

Interleukin 10 induced augmentation of delayed-type hypersensitivity (DTH) enhances Mycobacterium bovis bacillus Calmette-Guérin (BCG) mediated antitumour activity.

24 December 2019

cites work

1 reference

12 December 2020

The biology of chemokines and their receptors

1 reference

12 December 2020

Role of urothelial cells in BCG immunotherapy for superficial bladder cancer

1 reference

12 December 2020

Bacillus Calmette-Guerin immunotherapy of superficial bladder cancer.

1 reference

12 December 2020

Analysis of mucosal bladder leucocyte subpopulations in patients treated with intravesical Bacillus Calmette-Guerin

1 reference

12 December 2020

Effects of local bacillus Calmette-Guerin therapy in patients with bladder carcinoma on immunocompetent cells of the bladder wall

1 reference

12 December 2020

Elevations of cytokines interleukin-1, interleukin-2 and tumor necrosis factor in the urine of patients after intravesical bacillus Calmette-Guerin immunotherapy

1 reference

12 December 2020

Bacillus Calmette-Guérin (BCG): mechanism of action in superficial bladder cancer

1 reference

12 December 2020

Leukocytes in the urine after intravesical BCG treatment for superficial bladder cancer. A flow cytofluorometric analysis

1 reference

12 December 2020

Presence of activated lymphocytes in the urine of patients with superficial bladder cancer after intravesical immunotherapy with bacillus Calmette-Guérin

1 reference

12 December 2020

Leukocytes and cytokines in the urine of superficial bladder cancer patients after intravesical immunotherapy with bacillus Calmette-Guerin

1 reference

12 December 2020

Intravesical Evans strain BCG therapy: quantitative immunohistochemical analysis of the immune response within the bladder wall

1 reference

12 December 2020

Cytokine production by the human bladder carcinoma cell line T24 in the presence of bacillus Calmette-Guerin (BCG).

1 reference

12 December 2020

Recombinant Mycobacterium bovis BCG secreting functional interleukin-2 enhances gamma interferon production by splenocytes

1 reference

12 December 2020

Bacillus Calmette-Guérin immunotherapy for superficial bladder cancer. New prospects for an old warhorse

1 reference

12 December 2020

Interleukin-6 production by bladder tumors is upregulated by BCG immunotherapy

1 reference

12 December 2020

Urinary cytokines during intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer: processing, stability and prognostic value

1 reference

12 December 2020

Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells

1 reference

12 December 2020

Effects of bacillus Calmette-Guerin and interferon-alpha-2B on human bladder cancer in vitro

1 reference

12 December 2020

Effects of isoniazid on the proliferation and cytokine production of bladder cancer cells in vitro induced by bacille Calmette-Guérin

1 reference

12 December 2020

Urinary Interleukin-8 and 18 predict the response of superficial bladder cancer to intravesical therapy with bacillus Calmette-Guerin

1 reference

12 December 2020

Chemokines: immunology's high impact factors

1 reference

12 December 2020

Chemokines and disease

1 reference

12 December 2020

Evaluation of cellular tumour rejection mechanisms in the peritumoral bladder wall after bacillus Calmette-Guérin treatment.

1 reference

12 December 2020

T helper 1/2 lymphocyte urinary cytokine profiles in responding and nonresponding patients after 1 and 2 courses of bacillus Calmette-Guerin for superficial bladder cancer

1 reference

12 December 2020

Serial urinary IL-2, IL-6, IL-8, TNFalpha, UBC, CYFRA 21-1 and NMP22 during follow-up of patients with bladder cancer receiving intravesical BCG

1 reference

12 December 2020

Prognostic value of a T helper 1 urinary cytokine response after intravesical bacillus Calmette-Guerin treatment for superficial bladder cancer

1 reference

12 December 2020

1 reference

12 December 2020

Production of MCP-1 and RANTES in bladder cancer patients after bacillus Calmette-Guerin immunotherapy

1 reference

12 December 2020

Urinary interleukin-8 predicts the response of standard and low dose intravesical bacillus Calmette-Guerin (modified Danish 1331 strain) for superficial bladder cancer

1 reference

12 December 2020

BCG-induced interleukin-6 upregulation and BCG internalization in well and poorly differentiated human bladder cancer cell lines.

1 reference

12 December 2020

Intravesical bacille Calmette-Guérin induces the antiangiogenic chemokine interferon-inducible protein 10.

1 reference

12 December 2020

IFN-alpha 2B enhances Th1 cytokine responses in bladder cancer patients receiving Mycobacterium bovis bacillus Calmette-Guérin immunotherapy.

1 reference

12 December 2020

Effects of bacillus Calmette-Guèrin and interferon alpha-2B on cytokine production in human bladder cancer cell lines

1 reference

12 December 2020

BCG immunotherapy of bladder cancer: 20 years on.

1 reference

12 December 2020

The chemokine system: redundancy for robust outputs

1 reference

12 December 2020

Role of IL-12 in the induction and potentiation of IFN-gamma in response to bacillus Calmette-Guérin

1 reference

12 December 2020

Dermal fibroblasts represent a potent major source of human eotaxin: In vitro production and cytokine-mediated regulation

1 reference

12 December 2020

Interleukin-4 and 13 induce the expression and release of monocyte chemoattractant protein 1, interleukin-6 and stem cell factor from human detrusor smooth muscle cells: synergy with interleukin-1beta and tumor necrosis factor-alpha.

1 reference

12 December 2020

Human detrusor smooth muscle cells release interleukin-6, interleukin-8, and RANTES in response to proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha.

1 reference

12 December 2020

Endothelial and epithelial expression of eotaxin-2 (CCL24) in nasal polyps

1 reference

12 December 2020

Chemokines: a new classification system and their role in immunity

1 reference

12 December 2020

BCG-induced urinary cytokines inhibit microvascular endothelial cell proliferation

1 reference

12 December 2020

Chemokine receptors and their role in inflammation and infectious diseases

1 reference

12 December 2020

Monocyte chemoattractant protein-1 production by human detrusor smooth muscle cells

1 reference

12 December 2020

10.1111/J.1365-2249.2006.03288.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17223980%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference